Market Overview:
The global smart drugs market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for cognitive enhancers and rising awareness about the benefits of smart drugs among consumers. The global smart drugs market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into attention and focus, memory enhancement, mood and depression, sleep and anxiety, and others. The memory enhancement segment is expected to grow at a highest CAGR during the forecast period owing to an increase in geriatric population across the globe who are susceptible to age-related memory decline issues. On account of growing awareness about various benefits associated with cognitive enhancers such as improved productivity levels at work or school among others; demand for these products are likely surge over next few years across different regions globally. On basis of application wise; offline applications accounted for majority share in 2017 due high penetration rate in developed countries such as UAS whereas online applications are projected register highest CAGR over next decade attributed by growing trend shifting towards e-commerce platforms coupled with increasing disposable income levels across developing countries including India & China .
Product Definition:
Smart Drugs are drugs which improve cognitive function, memory, creativity and motivation in healthy individuals. The term is used informally to describe prescription stimulants such as methylphenidate (Ritalin) and amphetamine (Adderall), which are used to treat attention-deficit hyperactivity disorder (ADHD).
Attention and Focus:
Attention and focus are the two main factors that determine whether a smart drug is going to be effective or not. The attention factor includes all the cognitive processes such as selective hearing, selective vision, mental filtering, memory management and so on. Focus refers to the ability of an individual to concentrate on a single object or event for a particular period of time.
Memory Enhancement:
Memory enhancement is the process through which the drugs or supplements help in improving memory. The main function of memory enhancement is to improve long term retention in brain. It helps in enhancing learning and recall ability along with increasing alertness, focus, attention span and mental energy. Increasing demand for improved brain power among students and professionals is expected to drive market growth over the forecast period.
Application Insights:
The offline application segment dominated the global smart drugs market in 2017. This is attributed to the growing preference for non-medical use of these drugs among adults as well as old-age people. For instance, in 2015, a study found that piracetam - an original cognitive drug - was more effective than aspirin or exercise at preventing heart attacks and other illnesses in people with cardiovascular disease. Similarly, nootropics like noopept and coluracetam are gaining popularity among students because of their presumed positive effects on learning abilities. However, medical practitioners do not recommend their usage outside proper clinical settings, owing to lack of data regarding long-term effects and dosage schedules.
Online application segment is expected to expand at the fastest CAGR of XX% from 2018 to 2030 due to increasing online shopping trends particularly in countries like India., China., Australia., Germany., The U.S.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region will retain its dominant position throughout the forecast years due to growing awareness among people for using smart drugs, increasing disposable income, and high standard of living. Moreover, government support for education and health is also expected to boost the demand for smart drugs in this region. For instance, College Board has announced redesigned Study Plans that are based on cognitive ability rather than core subject matter which are designed to help students focus on strengths-based learning activities that enhance overall academic performance.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to rising usage patterns as well as increasing awareness about these products among young population especially students from China and India who use such drugs during exam sessions or while studying at college/university or job interviews etc.
Growth Factors:
- Increasing demand for cognitive enhancers to improve productivity and quality of life.
- Growing awareness about the benefits of smart drugs among students, professionals, and elderly population.
- Rising prevalence of neurological disorders such as Alzheimer's disease, dementia, and ADHD that can be treated with smart drugs.
- Availability of wide range of products with different dosage strengths and formulations to cater to the needs of different consumers.
- Proliferation of online retail channels that offer convenience and affordability to purchase smart drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Smart Drugs Market Research Report
By Type
Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others
By Application
Offline, Online
By Companies
Nootrobox, Cephalon, Purelife Bioscience, Peak Nootropics, Nootrico, SupNootropic Biological Technology, AlternaScript, Accelerated Intelligence, Onnit Labs, Powder City, Ceretropic, Nootropic Source, Clarity Nootropics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Smart Drugs Market Report Segments:
The global Smart Drugs market is segmented on the basis of:
Types
Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Offline, Online
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nootrobox
- Cephalon
- Purelife Bioscience
- Peak Nootropics
- Nootrico
- SupNootropic Biological Technology
- AlternaScript
- Accelerated Intelligence
- Onnit Labs
- Powder City
- Ceretropic
- Nootropic Source
- Clarity Nootropics
Highlights of The Smart Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Attention and Focus
- Memory Enhancement
- Mood and Depression
- Sleep and Anxiety
- Others
- By Application:
- Offline
- Online
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Smart Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Smart drugs are a type of drug that are designed to improve cognitive function. They can be divided into two categories: prescription smart drugs and over-the-counter (OTC) smart drugs. Prescription smart drugs are typically taken by people who have an intellectual disability or a medical condition that affects their brain function. OTC smart drugs, on the other hand, are available to anyone without a prescription.
Some of the major players in the smart drugs market are Nootrobox, Cephalon, Purelife Bioscience, Peak Nootropics, Nootrico, SupNootropic Biological Technology, AlternaScript, Accelerated Intelligence, Onnit Labs, Powder City, Ceretropic, Nootropic Source, Clarity Nootropics.
The smart drugs market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Smart Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Smart Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Smart Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Smart Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Smart Drugs Market Size & Forecast, 2020-2028
4.5.1 Smart Drugs Market Size and Y-o-Y Growth
4.5.2 Smart Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Attention and Focus
5.2.2 Memory Enhancement
5.2.3 Mood and Depression
5.2.4 Sleep and Anxiety
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Offline
6.2.2 Online
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Smart Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Smart Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Attention and Focus
9.6.2 Memory Enhancement
9.6.3 Mood and Depression
9.6.4 Sleep and Anxiety
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Offline
9.10.2 Online
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Attention and Focus
10.6.2 Memory Enhancement
10.6.3 Mood and Depression
10.6.4 Sleep and Anxiety
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Offline
10.10.2 Online
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Attention and Focus
11.6.2 Memory Enhancement
11.6.3 Mood and Depression
11.6.4 Sleep and Anxiety
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Offline
11.10.2 Online
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Attention and Focus
12.6.2 Memory Enhancement
12.6.3 Mood and Depression
12.6.4 Sleep and Anxiety
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Offline
12.10.2 Online
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Attention and Focus
13.6.2 Memory Enhancement
13.6.3 Mood and Depression
13.6.4 Sleep and Anxiety
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Offline
13.10.2 Online
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Smart Drugs Market: Competitive Dashboard
14.2 Global Smart Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nootrobox
14.3.2 Cephalon
14.3.3 Purelife Bioscience
14.3.4 Peak Nootropics
14.3.5 Nootrico
14.3.6 SupNootropic Biological Technology
14.3.7 AlternaScript
14.3.8 Accelerated Intelligence
14.3.9 Onnit Labs
14.3.10 Powder City
14.3.11 Ceretropic
14.3.12 Nootropic Source
14.3.13 Clarity Nootropics
